BREAKING: The FDA has approved the first pill to treat postpartum depression.
The Food and Drug Administration announced Friday it has approved the first oral treatment for postpartum depression. The drug, called zuranolone, is a once-a-day pill that will be branded as Zurzuvae by drugmakers Sage Therapeutics and Biogen. , an episode of major depression that can begin after childbirth or the later stages of pregnancy, which affects an estimated 15% of women in the weeks or months after having a baby.
"Having access to an oral medication will be a beneficial option for many of these women coping with extreme, and sometimes life-threatening, feelings," Dr. Tiffany Farchione, director of the Division of Psychiatry in the FDA's Center for Drug Evaluation and Research, said in a
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves first-ever pill for postpartum depression in new mothersBiogen and Sage Therapeutics are behind the first FDA-approved pill for treating postpartum depression.
Read more »
DEA, FDA Address Adderall Shortage by Urging Drugmakers to Boost ProductionNearly a year after the Adderall shortage began, two federal agencies call on drugmakers to increase production of prescription stimulants and health care providers to explore alternative ADHD treatments like digital therapeutics and non-stimulants.
Read more »
Amid Shortages, Federal Agencies Ask Drugmakers to Boost Output of ADHD MedsWhile demand for prescription stimulants is surging, a shortage of the drugs persists, so federal officials have stepped in and asked drug companies to ramp up production of the medications.
Read more »
First-ever pill for postpartum depression is up for FDA approval this weekThe FDA is expected to decide by Saturday whether to approve the first-ever pill for postpartum depression. If approved, it will become the first treatment that can be taken at home.
Read more »
First-ever pill for postpartum depression is up for FDA approval this weekThe Food and Drug Administration is expected to decide by Saturday whether to approve the first-ever pill for postpartum depression.
Read more »